microRNA as Biomarkers and Diagnostics 2014
Conference, Course - Boston, MA, United States
Recent research has shown microRNAs to have tremendous potential as non-invasive biomarkers for the diagnosis and prognosis of disease, monitoring of treatment, and patient stratification, with exosome-derived microRNAs of particular interest. Cambridge Healthtech Institute's Tenth Annual microRNA as Biomarkers and Diagnostics will cover the latest developments in the use of microRNA in the early detection of disease for more effective treatment, monitoring tumor growth and disease progression, issues associated with microRNA measurement, and the potential for personalized medicine based on microRNA profile.
Topics Include:
Circulating microRNAs as biomarkers of disease
microRNAs in cancer diagnosis and prognosis
Utility in monitoring tumor growth and progression
Exosome-derived microRNAs as biomarkers
microRNA biomarkers of drug toxicity
microRNA isolation and profiling approaches
microRNA quantification and normalization
microRNA in patient stratification and personalized medicine
Organization: Cambridge Healthtech Institute (CHI)
(Courtesy of microRNA as Biomarkers and Diagnostics logo, via giiconference.com)
Website: www.healthtech.com/microRNA
17–18 March 2014
Omni Parker House
Boston, MA, United States
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
